| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | Y66IS3CS0R |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tyrosine-protein kinase receptor FLT3 inhibitor | PubMed |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 3 | |
| KIT proto-oncogene, receptor tyrosine kinase |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1175017-90-9 |
| ChEMBL | CHEMBL3545281 |
| FDA SRS | Y66IS3CS0R |
| Guide to Pharmacology | 7969 |
| PubChem | 44177328 |
CONTENTS